Article

Urologist Raoul Concepcion Explains Gleason Score and Gleason Grade

Raoul Concepcion, a urologist with Urology Associates in Nashville, Tenn., explains Gleason score and Gleason grade as it relates to a prostate cancer diagnosis.

Raoul Concepcion, a urologist with Urology Associates in Nashville, Tenn., explains Gleason score and Gleason grade as it relates to a prostate cancer diagnosis. Features that define prostate cancer fall under Gleason grade and score. Gleason grade ranges from 1 to 5, where 5 is considered most aggressive.

Prostate cancer can be heterogeneous, so in the same biopsy, the sample may show different grades, or patterns. The Gleason score is the sum of the two most common patterns. For example, a biopsy may reveal a Gleason grade of 4 as the most prevalent pattern, with 3 as the second. The Gleason score would be a 7.

"A lot of people will say 'I have a Gleason 7 score.' I personally tend to stay away from the summation only because if you think about a 7, there are a number of different ways you can get to a 7 with a grading scale of one through five," he says. "It could be a 3 plus 4... or a 2 plus 5."

With the first number being the most prominent, urologists may treat according to the more dominant pattern than simply the Gleason score.

"If you have one patient with a Gleason 3 plus 4 and another patient with a 4 plus 3, they are both 7s, but we actually look at those patients very differently," he says."The 4 plus 3 is at a much higher risk than the gentleman with a 3 plus 4."

Related Videos
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
Image of woman.
Image of woman.
Image of woman.
Image of man wearing baseball cap backwards.
Image of smiling doctor.
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
Image od grey haired Doctor.
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
Related Content